Arginine

Arginine

SCHEMBL28276672

CC(O)CC(=O)O.C[N+](C)(C)CC(O)CC(=O)[O-].N=C(N)NCCCC(N)C(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACES1PR1S1PR4S1PR5

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SLC22A16 Q86VW1 1/20 0.43
▸ MAPT P10636 1/20 0.38
▸ CPT2 P23786 2/20 0.36
▸ CPT1A P50416 2/20 0.36
▸ OTC P00480 1/20 0.36
▸ NOS3 P29474 2/20 0.34
▸ NOS1 P29475 2/20 0.34
▸ NOS2 P35228 2/20 0.34
▸ CPT1B Q92523 1/20 0.34
▸ DDAH1 O94760 1/20 0.34
▸ ITGB3 P05106 2/20 0.33
▸ ITGA2B P08514 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL27902011 0.93 SLC22A16 (0.50) SLC22A16MAPTCPT2CPT1AOTC
Arginine SCHEMBL27492468 0.92 SLC22A16 (0.49) SLC22A16MAPTCPT2CPT1AOTC
Arginine SCHEMBL15323966 0.90 SLC22A16 (0.43) SLC22A16CPT2CPT1AOTCNOS3
Arginine SCHEMBL1462462 0.88 SLC22A16 (0.44) SLC22A16MAPTCPT2CPT1AOTC
Arginine SCHEMBL22577747 0.88 SLC22A16 (0.44) SLC22A16MAPTCPT2CPT1AOTC
Arginine SCHEMBL16099880 0.87 OTC (0.44) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL16099882 0.87 OTC (0.44) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL19459580 0.87 OTC (0.44) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL15323382 0.85 MAPT (0.39) SLC22A16MAPTOTCNOS3NOS1
Arginine SCHEMBL15322680 0.84 MAPT (0.40) SLC22A16MAPTOTCNOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109394745-A A kind of composition comprising L-carnitine and beta-hydroxy-butanoic acid compound 博瑞生物医药(苏州)股份有限公司 2019-03-01 — — CN disclosed
Send feedback